Dendreon Announces Webcast Presentation at UBS Life Sciences ... ( SEATTLE Sept. 18 /- Dendreon Corp...)

Dendreon Announces Webcast Presentation at UBS Life Sciences Conference

Date:9/18/2007

SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will participate in the UBS Global Life Sciences Conference.

UBS Global Life Sciences Conference

Grand Hyatt New York

Thursday, September 27, 2007

9:00 a.m. ET

The presentation will be audio webcast live and available for replay from Dendreon's website, http://www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

SOURCE Dendreon Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/9/2009)... , BEIJING, Nov. 9 /PRNewswire-Asia-First... ), ("Yongye or "the Company") a leading manufactu...d plant and animal nutrient products in the,People...t will conduct a,conference call at 10:00 a.m. Eas...ember 16, 2009 to discuss results for the quarter ...

(Date:11/9/2009)... , VIENNA, Va., Nov. 9 /PRNewswire-FirstCall/...ed today that Dr. Kenneth S. Rosenthal, Professor ...o Universities College of Medicine and Pharmacy, r...ientists at the Cleveland Clinic and CEL-SCI on CE...esented at the 7th GTCbio Vaccine: "All Things Con...

(Date:11/8/2009)... , , MOUNTAIN VIEW, Calif. Nov. 5, 2009 Co...equencing company, today announced publication of ...roprietary DNA sequencing platform, including anal...nomes. The consumables cost for these three genome...nanoarrays ranged from $8,005 for 87x coverage to ...

(Date:11/6/2009)... , QUINCY, Mass., Nov. 6 Myri..., biotech developer and manufacturer of renewable...s preferred technology provider Uhde GmbH, one of ...ly "Uhde"), announced an alliance for the engineer...nt,s biobased Succinic Acid plants based on renewa...

Breaking Biology Technology:Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2 Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3 CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2 CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3 Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2 Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2 Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3

[0] Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results [0] CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response [0] Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes [1] Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants

...ovac Biotech Ltd. (Amex:,SVA), a leading provider ...notified the Listing Qualifications Department at ...defer its 2007 annual stockholders meeting,to no l... scheduled its 2007 annual stockholders meeting,in...e Company could not,form the necessary quorum, whi...

...e-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIFF)...us,diseases, reports financial results for the thr...ts programs., UPDATE ON DRUG DEVELOPMENT PROGRAMS...pical cationic peptide;,prevention of catheter-rel...conducted by our development and commercialization...

...ation studies,were published during 2007 on the Si...ging the total number of studies published to 65.,...in interest from US and,European institutes" said ...most highly respected academic medical institution...asuring the efficacy of using Simbionix Mentor,sim...

Sinovac Requests Extension for Annual Shareholders Meeting MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators

(Date:11/9/2009)...method that begins by soaking corn kernels rather ...anol and more usable co-products, giving ethanol p... percent. , "The conventional ethanol production... dried grains with soluble, it doesn,t have any ot...cultural Engineer Esha Khullar. "Whereas in both w...

(Date:11/9/2009)... of Energy (DOE) has announced plans to fund resea...B) School of Engineering on technologies that woul... capture and permanent safe storage, or sequestrat...llaboration with Southern Company, the parent comp...h the 2009 American Recovery and Reinvestment Act,...

(Date:11/9/2009)... inspired a 3.2m, three-year research project that...ecurity, energy and the environment. The Universit...inetiQ have just signed a collaborative contract t... physical sciences research. , Over the next th... of Exeter and QinetiQ will work together to devel...

Breaking Biology News(10 mins):Wet ethanol production process yields more ethanol and more co-products 2 UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2 UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3 £3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2 The vasculature emerges as a potential therapeutic target in treating ADPKD liver cysts 10070 1 The vasculature emerges as a potential therapeutic target in treating ADPKD liver cysts 10070 2 Minorities Less Likely to Have Blood Pressure Under Control 58190 1 Minorities Less Likely to Have Blood Pressure Under Control 58190 2 Minorities Less Likely to Have Blood Pressure Under Control 58190 3 AbilityLinks org to Host Virtual Job Fair 58187 1 AbilityLinks org to Host Virtual Job Fair 58187 2

[0] Wet ethanol production process yields more ethanol and more co-products [0] UAB, partners seek safe carbon dioxide storage for 'greener' power generation [0] £3.2m ($5.4 million) research project to capture brilliance of butterfly wings

...e UAV, Biometric Technology on Heels of ...s to Offer Free Training to Law Enforcement on Sur...vival, AUSTIN, Texas, April 21 A coalition of Te... Paso to Brownsville joined a,class-action lawsuit...off,recently which challenges the impact the propo...

... what we eat, may be the latest recipe for success...mate warming. Despite the recent popular attentio...late, aka food miles, Carnegie Mellon researchers ...n an upcoming article in the prestigious Environme...ry choice, not food miles, which most determines a...

...that links specific pieces of RNA to an infectious...ay to the prevention of viroids, pathogens that ca...The findings and the research approach used by Ohi...ications in the study of how certain viruses sprea...r characteristics. , The researchers have develop...

Other Biology News:Government, Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security, Surveillance 2 Government, Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security, Surveillance 3 Carnegie Mellon studies how climate change impacts food production 2 Analysis of RNA role in spreading disease advances study of damaging plant infections 2 Analysis of RNA role in spreading disease advances study of damaging plant infections 3 Analysis of RNA role in spreading disease advances study of damaging plant infections 4

Government, Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security, Surveillance Carnegie Mellon studies how climate change impacts food production Analysis of RNA role in spreading disease advances study of damaging plant infections

MHC Volumes 1 & 2 from Promega

Custom Production Service from AbD Serotec

MitoScreen (JC-1) Kit from BD Biosciences Pharmingen

Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG

Biology Products:

MHC Volumes 1 & 2 from Promega Custom Production Service from AbD Serotec MitoScreen (JC-1) Kit from BD Biosciences Pharmingen Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG

Dendreon Announces Webcast Presentation at UBS Life Sciences ...( SEATTLE Sept. 18 /- Dendreon Corp...)